ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1449

Numbers of Splenic Long-Lived Plasma Cells in Autoimmune and Pre-Autoimmune Lupus Mice Are Linked to a Hyper-Responsive Variant of the Thrombopoietin Receptor and Enhanced Megakaryopoiesis

Oliver Winter1, Katrin Moser2, Rudolf A. Manz3 and Falk Hiepe4, 1Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Berlin, Germany, 2German Arthritis Research Center (DRFZ Berlin), Berlin, Germany, 3Institute for Systemic Inflammation Research (ISEF), University of Lübeck, Lübeck, Germany, 4Med. Klinik m. Sp. Rheumatologie und klin. Immunologie, Charité University Hospital Berlin, Berlin, Germany

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: autoantibodies, memory, plasma cells and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Autoantibodies contribute to the pathogenesis of the autoimmune disease Systemic Lupus Erythematosus (SLE) by stimulating the immune response. Further, deposits of immune complexes in the kidneys can lead to severe nephritis. The autoantibodies are secreted by short- and long-lived plasma cells located in the bone marrow and in the spleen. In NZB/W mice – a mouse model for SLE – both parental strains New Zealand Black (NZB) and New Zealand White (NZW) contribute different sle-loci to the formation of SLE. The NZB strain passes the sle2c locus in which the gene for the Thrombopoietin (TPO)-receptor (c-mpl) is located.

According to the relevance of megakaryocytes for the plasma cell niche and the correlation between plasma cell and megakaryocyte numbers, we wanted to elucidate whether c-Mpl and/ or megakaryopoiesis is altered in auto-immune mice.

Methods:

Therefore, we examined in wild type, NZB and NZW mice the amount of megakaryocytes and plasma cells in spleen and bone marrow, the occurrence of genetic variations for c-mpl and the degree of megakaryopoiesis upon TPO stimulation by histological survey, flow-cytometric and genetic analysis and by in vitrostudies.

Results:

We found, that in the spleen of NZB mice the number of long-lived plasma cells and megakaryocytes are 10-times higher than in wild type while in NZW mice the numbers are equal. We detected a missense mutation in the c-mpl gene of NZB mice leading to an amino acid replacement within the essential TPO-binding site. Upon TPO stimulation of splenocyte and bone marrow cultures NZB cultures responded significantly stronger resulting in the double amount of megakaryocytes compared to NZW cultures.

Conclusion:

In summary, our data indicate that the mutated c-mpl gene located within the sle2c-locus is leading to an augmented megakaryopoiesis which enables the accumulation of a greater number of autoreactive plasma cells and thus is contributing to the development of SLE.


Disclosure:

O. Winter,
None;

K. Moser,
None;

R. A. Manz,
None;

F. Hiepe,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/numbers-of-splenic-long-lived-plasma-cells-in-autoimmune-and-pre-autoimmune-lupus-mice-are-linked-to-a-hyper-responsive-variant-of-the-thrombopoietin-receptor-and-enhanced-megakaryopoiesis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology